Cargando…
Rifamycin W Analogues from Amycolatopsis mediterranei S699 Δrif-orf5 Strain
Rifamycin W, the most predominant intermediate in the biosynthesis of rifamycin, needs to undergo polyketide backbone rearrangement to produce rifamycin B via an oxidative cleavage of the C-12/C-29 double bond. However, the mechanism of this putative oxidative cleavage has not been characterized yet...
Autores principales: | Shi, Yanrong, Ye, Feng, Song, Yuliang, Zhang, Xiaochun, Lu, Chunhua, Shen, Yuemao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301457/ https://www.ncbi.nlm.nih.gov/pubmed/34206314 http://dx.doi.org/10.3390/biom11070920 |
Ejemplares similares
-
8-Deoxy-Rifamycin Derivatives from Amycolatopsis mediterranei S699 ΔrifT Strain
por: Ye, Feng, et al.
Publicado: (2020) -
A feedback regulatory model for RifQ-mediated repression of rifamycin export in Amycolatopsis mediterranei
por: Lei, Chao, et al.
Publicado: (2018) -
Hierarchical amino acid utilization and its influence on fermentation dynamics: rifamycin B fermentation using Amycolatopsis mediterranei S699, a case study
por: Bapat, Prashant M, et al.
Publicado: (2006) -
GlnR Dominates Rifamycin Biosynthesis by Activating the rif Cluster Genes Transcription Both Directly and Indirectly in Amycolatopsis mediterranei
por: Liu, Xinqiang, et al.
Publicado: (2020) -
Draft Genome Sequence of Rifamycin Derivatives Producing Amycolatopsis mediterranei Strain DSM 46096/S955
por: Singh, Priya, et al.
Publicado: (2014)